• Articles |
• News & Analysis |
• Products |
• Archives Home

News & Analysis 2008 p2:

• Study shows "mild" laser effective, non-damaging for retinal regeneration
  NOVEMBER 11, 2008 -- Ellex Medical Lasers (Adelaide, Australia) announced results of a six-month clinical study for retina regeneration during this week's American Academy of Ophthalmology meeting. The results show that Ellex's 2RT laser is safe and effective in treatment of macular edema secondary to diabetic retinopathy. "For the first time, we can obtain all the therapeutic benefits seen with earlier laser treatments, but without the collateral damage," said study leader Dr. John Marshall.
• Canon highlights OCT/retinal imaging synergy among eye care line
  NOVEMBER 11, 2008 -- Canon USA (Lake Success, NY) is showcasing its "complete line of total digital imaging and workflow management solutions for eyecare professionals" this week at this week's American Academy of Ophthalmology annual meeting. In particular, Canon is demonstrating synergy between its own retinal cameras and optical coherence tomography (OCT) products from Optopol Technology SA (Zawiercie, Poland) -- which Canon is now distributing in the US.
• Fractional lasers best, says study presented at dermatology meeting
  NOVEMBER 10, 2008 -- Reliant Technologies (Mountain View, CA) presented study results comparing fractional laser technology to pseudo fractional lasers during last week's American Society for Dermatologic Surgery meeting. The data demonstrates that "true" fractional systems provide superior safety and efficacy compared to those that use altered ablative technology. The lasers are used for for skin resurfacing and rejuvenation on the face, eyelids, the neck, and hands, as well as on scars.
• Carl Zeiss Meditec intros ophthalmic innovations
  NOVEMBER 10, 2008 -- Carl Zeiss Meditec (Dublin, CA) is announcing new and updated technology at this week's American Academy of Ophthalmology (AAO) meeting. The new systems include diagnostic and surgical applications covering the entire spectrum of patient care and supporting cataract/refractive, retina and glaucoma treatment. Technologies include coaxial illumination, photocoagulation, optical coherence tomography, femtosecond lasers, and intraocular lenses (IOLs).
• Lumenis targets ophthalmology with four new lasers at AAO meeting
  NOVEMBER 9, 2008 -- Lumenis Ltd. (Yokneam, Israel) has introduced four new ophthalmic lasers and delivery devices at the American Academy of Ophthalmology (AAO) annual meeting, which began Friday. The company is demonstrating two units that combine technologies and applications for flexibility and performance; a powerful dual-port photocoagulator; and a family of endo photocoagulation laser probes for retinal applications.
• Peloton Diagnostics founder chosen for Ernst & Young Strategic Growth Forum
  NOVEMBER 9, 2008 -- Linda Smith, founder of Peloton Diagnostics Corp. (Wellesley, MA) is one of five women entrepenuers selected to participate in the inauguration of Ernst & Young Strategic Growth Forum 2008, (November 12-16, Palm Springs, CA). Peloton Diagnostics supplies medical diagnostics tools based on optical imaging technologies that promise to advance preventative and personalized medicine.
• Medical laser rental company Emergent Group to trade on NYSE Alternext US
  NOVEMBER 7, 2008 -- Emergent Group Inc. (Sun Valley, CA), provider of mobile medical and cosmetic lasers and surgical equipment, has been approved for listing on the NYSE Alternext US, formerly the American Stock Exchange. The company anticipates trading on the exchange to begin the week of November 10 under the ticker symbol "LZR".
• Ahura says growth due to demand for portable, handheld spectrometers
  NOVEMBER 6, 2008 -- Ahura Scientific (Wilmington, MA) today announced a corporate milestone: shipment of 2000 chemical identification devices. Ahura says the achievement follows increasing demand for its award-winning Raman spectroscopy-based FirstDefender and TruScan instruments, and its newest product, TruDefender FT, based on Fourier-Transform Infrared (FTIR) spectroscopy. Ahura shipped its first product in May 2005; pharmaceuticals giant AstraZeneca PLC purchased the 2000th unit.
• Syneron acquires Inlight, plans new skin-rejuvenation offerings
  NOVEMBER 6, 2008 -- Syneron Medical Ltd. (Yokneam, Israel), developer of medical aesthetic devices, has agreed to acquire laser technology firm Inlight Corp. (San Diego, CA). As part of the agreement, Inlight president and co-founder Shlomo Assa, who holds multiple U.S. patents for laser-based technology, will join the Syneron management team. Syneron will leverage Inlight technology for new laser skin care products, to launch starting in 2009.
• Partnership yields portable, long-wavelength Raman spectroscopy for biomedical apps
  NOVEMBER 5, 2008 -- Biomedical and analytical instrumentation has long had need for long-wavelength excitation Raman spectroscopy for lab, hospital bedside, and portable field work. Now BaySpec Inc. (Fremont, CA) and Andor Technology (Belfast, Northern Ireland) say their collaboration has yielded a solution: new technology with 1064nm capability that enables up to three times the collection efficiency of standard Czerny-Turner spectrographs.

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 |